 Swiss National Bank increased its position in shares of Aimmune Therapeutics Inc NASDAQ:AIMT by 2.5 during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 73,674 shares of the biotechnology companys stock after buying an additional 1,800 shares during the period. Swiss National ... 